Recent Finacing
Recent Raise
Synlogic engineers therapeutic microbes using a proprietary platform to sense physiological signals, perform targeted metabolic interventions (e.g., UCD, PKU) and self-deactivate, with programs for GI/IBD applications.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors